Special report profile: John MacDonell, and a case study for the Future of Work
What’s the Future of Work look like for new, emerging, and growth-stage companies in the Triangle’s life science sector? It may look like this.
Read MorePosted by Jason Parker | May 17, 2022
What’s the Future of Work look like for new, emerging, and growth-stage companies in the Triangle’s life science sector? It may look like this.
Read MorePosted by Jason Parker | May 17, 2022
Life science is a booming industry sector, and the Triangle is strong in biomanufacturing. Plus, gene therapy companies are on the rise. What’s next?
Read MorePosted by Jason Parker | May 17, 2022
Statistically, there’s no available life science or lab space available in the Triangle, an executive told WRAL TechWire for the Future of Work series.
Read MorePosted by Jason Parker | May 17, 2022
There are four factors that life science and biopharma companies are considering when making decisions about where to build or expand facilities.
Read MorePosted by Jason Parker | May 16, 2022
The Triangle’s strength in biopharmaceutical manufacturing is a great strength for the region’s economy. But it’s also a weakness, one executive says.
Read MorePosted by Jason Parker | May 16, 2022
The WRAL TechWire Future of Work series continues next week, with an in-depth look at the life science sector. Here’s what to expect.
Read More